ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
3 |
04/10/19 |
04/10/19 |
ASX - By Stock
|
302
|
219K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
346K |
14 |
03/10/19 |
03/10/19 |
ASX - By Stock
|
595
|
346K
|
14
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
346K |
6 |
03/10/19 |
03/10/19 |
ASX - By Stock
|
595
|
346K
|
6
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
6 |
02/10/19 |
02/10/19 |
ASX - By Stock
|
302
|
219K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
346K |
4 |
30/09/19 |
30/09/19 |
ASX - By Stock
|
595
|
346K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
346K |
5 |
26/09/19 |
26/09/19 |
ASX - By Stock
|
595
|
346K
|
5
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
1 |
23/09/19 |
23/09/19 |
ASX - By Stock
|
302
|
219K
|
1
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
3 |
23/09/19 |
23/09/19 |
ASX - By Stock
|
302
|
219K
|
3
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
2 |
23/09/19 |
23/09/19 |
ASX - By Stock
|
302
|
219K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
346K |
6 |
23/09/19 |
23/09/19 |
ASX - By Stock
|
595
|
346K
|
6
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
8 |
23/09/19 |
23/09/19 |
ASX - By Stock
|
302
|
219K
|
8
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
7 |
23/09/19 |
23/09/19 |
ASX - By Stock
|
302
|
219K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
346K |
7 |
20/09/19 |
20/09/19 |
ASX - By Stock
|
595
|
346K
|
7
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
3 |
18/09/19 |
18/09/19 |
ASX - By Stock
|
302
|
219K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
346K |
7 |
18/09/19 |
18/09/19 |
ASX - By Stock
|
595
|
346K
|
7
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
8 |
18/09/19 |
18/09/19 |
ASX - By Stock
|
302
|
219K
|
8
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
0 |
18/09/19 |
18/09/19 |
ASX - By Stock
|
302
|
219K
|
0
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
3 |
18/09/19 |
18/09/19 |
ASX - By Stock
|
302
|
219K
|
3
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
4 |
18/09/19 |
18/09/19 |
ASX - By Stock
|
302
|
219K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase II DMD clinical trial on track for dosing completion
|
|
Blockbuster
|
22 |
9.2K |
4 |
18/09/19 |
18/09/19 |
ASX - By Stock
|
22
|
9.2K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
346K |
10 |
18/09/19 |
18/09/19 |
ASX - By Stock
|
595
|
346K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
346K |
10 |
18/09/19 |
18/09/19 |
ASX - By Stock
|
595
|
346K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive preliminary results from ATL1102 DMD Phase II trial
|
|
Blockbuster
|
595 |
346K |
11 |
18/09/19 |
18/09/19 |
ASX - By Stock
|
595
|
346K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
Blockbuster
|
51 |
22K |
3 |
17/09/19 |
17/09/19 |
ASX - By Stock
|
51
|
22K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Acromegaly Early Access Program Status Update
|
|
Blockbuster
|
80 |
30K |
8 |
27/08/19 |
27/08/19 |
ASX - By Stock
|
80
|
30K
|
8
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
7 |
21/08/19 |
21/08/19 |
ASX - By Stock
|
302
|
219K
|
7
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
7 |
21/08/19 |
21/08/19 |
ASX - By Stock
|
302
|
219K
|
7
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
4 |
21/08/19 |
21/08/19 |
ASX - By Stock
|
302
|
219K
|
4
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
4 |
20/08/19 |
20/08/19 |
ASX - By Stock
|
302
|
219K
|
4
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
4 |
20/08/19 |
20/08/19 |
ASX - By Stock
|
302
|
219K
|
4
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
6 |
20/08/19 |
20/08/19 |
ASX - By Stock
|
302
|
219K
|
6
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
2 |
20/08/19 |
20/08/19 |
ASX - By Stock
|
302
|
219K
|
2
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
2 |
20/08/19 |
20/08/19 |
ASX - By Stock
|
302
|
219K
|
2
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
6 |
19/08/19 |
19/08/19 |
ASX - By Stock
|
302
|
219K
|
6
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
7 |
16/08/19 |
16/08/19 |
ASX - By Stock
|
302
|
219K
|
7
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
3 |
16/08/19 |
16/08/19 |
ASX - By Stock
|
302
|
219K
|
3
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
1 |
16/08/19 |
16/08/19 |
ASX - By Stock
|
302
|
219K
|
1
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
0 |
15/08/19 |
15/08/19 |
ASX - By Stock
|
302
|
219K
|
0
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
4 |
15/08/19 |
15/08/19 |
ASX - By Stock
|
302
|
219K
|
4
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
4 |
15/08/19 |
15/08/19 |
ASX - By Stock
|
302
|
219K
|
4
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
5 |
15/08/19 |
15/08/19 |
ASX - By Stock
|
302
|
219K
|
5
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
5 |
14/08/19 |
14/08/19 |
ASX - By Stock
|
302
|
219K
|
5
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
4 |
14/08/19 |
14/08/19 |
ASX - By Stock
|
302
|
219K
|
4
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
5 |
14/08/19 |
14/08/19 |
ASX - By Stock
|
302
|
219K
|
5
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
7 |
14/08/19 |
14/08/19 |
ASX - By Stock
|
302
|
219K
|
7
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
1 |
13/08/19 |
13/08/19 |
ASX - By Stock
|
302
|
219K
|
1
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
4 |
13/08/19 |
13/08/19 |
ASX - By Stock
|
302
|
219K
|
4
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
5 |
13/08/19 |
13/08/19 |
ASX - By Stock
|
302
|
219K
|
5
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
8 |
12/08/19 |
12/08/19 |
ASX - By Stock
|
302
|
219K
|
8
|
|
ASX - By Stock
|
PER |
Re:
DMD Phase 2 Results in Q4 = Potential 5000% Gem
|
|
Blockbuster
|
302 |
219K |
5 |
12/08/19 |
12/08/19 |
ASX - By Stock
|
302
|
219K
|
5
|
|